ARWR vs EXEL
Arrowhead Pharmaceuticals vs Exelixis — AI-powered side-by-side comparison
| Metric | ARWR | EXEL |
|---|---|---|
| AI Score | 51 | 63 |
| Price | $84.64 | $53.05 |
| P/E Ratio | -39.56× | 17.00× |
| ROE | -0.0% | 0.4% |
| Revenue Growth YoY | — | — |
| Gross Margin | 1.0% | 1.0% |
| Debt / Equity | 2.24× | 0.09× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 56.3 | 31.9 |
| Beta | 1.265 | 0.424 |
| Expected Upside | +2.5% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ARWR Full Analysis
EXEL Full Analysis